• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Doximity Inc. (Amendment)

    2/14/24 2:47:49 PM ET
    $DOCS
    EDP Services
    Technology
    Get the next $DOCS alert in real time by email
    SC 13G/A 1 d786222dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No. 2)*

     

     

    Doximity, Inc.

    (Name of Issuer)

    CLASS A COMMON STOCK, $0.001 PAR VALUE PER SHARE

    (Title of Class of Securities)

    26622P107

    (CUSIP Number)

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 26622P107    SCHEDULE 13G    Page 2 of 10 Pages

     

     1.   

     NAMES OF REPORTING PERSONS

     

     Emergence Capital Partners II, L.P.

     2.  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3.  

     SEC USE ONLY

     

     4.  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.    

     SOLE VOTING POWER

     

     14,462,728 (1)(2)

       6.   

     SHARED VOTING POWER

     

     -0-

       7.   

     SOLE DISPOSITIVE POWER

     

     14,462,728 (1)(2)

       8.   

     SHARED DISPOSITIVE POWER

     

     -0-

     9.   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     14,462,728 (1)(2)

    10.  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11.  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

     10.9% (2)(3)(4)

    12.  

     TYPE OF REPORTING PERSON

     

     PN

     

    (1)

    Represents 14,462,728 shares of Class B Common Stock held directly by Emergence Capital Partners II, L.P.

    (2)

    Each share of Class A Common Stock is entitled to one vote, and each share of Class B Common Stock is entitled to ten votes. Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon certain events specified in the Issuer’s certificate of incorporation.

    (3)

    The percent of class was calculated based on 118,159,500 shares of Class A Common Stock outstanding as of November 2, 2023, as set forth in the Issuer’s Form 10-Q for the period ended September 30, 2023, and filed with the Securities and Exchange Commission on November 9, 2023.

    (4)

    Pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, the Class B Common Stock beneficially owned by the reporting person is treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person.


    CUSIP No. 26622P107    SCHEDULE 13G    Page 3 of 10 Pages

     

     1.   

     NAMES OF REPORTING PERSONS

     

     Emergence Capital Opportunity I, L.P.

     2.  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3.  

     SEC USE ONLY

     

     4.  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.    

     SOLE VOTING POWER

     

     775,000 (1)

       6.   

     SHARED VOTING POWER

     

     -0-

       7.   

     SOLE DISPOSITIVE POWER

     

     775,000 (1)

       8.   

     SHARED DISPOSITIVE POWER

     

     -0-

     9.   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     775,000 (1)

    10.  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11.  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

     0.7% (2)

    12.  

     TYPE OF REPORTING PERSON

     

     PN

     

    (1)

    Represents 775,000 shares of Class A Common Stock held directly by Emergence Capital Opportunity I, L.P.

    (2)

    The percent of class was calculated based on 118,159,500 shares of Class A Common Stock outstanding as of November 2, 2023, as set forth in the Issuer’s Form 10-Q for the period ended September 30, 2023, and filed with the Securities and Exchange Commission on November 9, 2023.


    CUSIP No. 26622P107    SCHEDULE 13G    Page 4 of 10 Pages

     

     1.   

     NAMES OF REPORTING PERSONS

     

     Emergence Equity Partners II, L.P.

     2.  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3.  

     SEC USE ONLY

     

     4.  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.    

     SOLE VOTING POWER

     

     14,462,728(1)(2)

       6.   

     SHARED VOTING POWER

     

     -0-

       7.   

     SOLE DISPOSITIVE POWER

     

     14,462,728(1)(2)

       8.   

     SHARED DISPOSITIVE POWER

     

     -0-

     9.   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     14,462,728(1)(2)

    10.  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11.  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

     10.9% (2)(3)(4)

    12.  

     TYPE OF REPORTING PERSON

     

     PN

     

    (1)

    Represents 14,462,728 shares of Class B Common Stock held directly by Emergence Capital Partners II, L.P. (“ECP II”). Emergence Equity Partners II, L.P. is the sole general partner of ECP II, and may be deemed to beneficially own the shares of stock held directly by ECP II.

    (2)

    Each share of Class A Common Stock is entitled to one vote, and each share of Class B Common Stock is entitled to ten votes. Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon certain events specified in the Issuer’s certificate of incorporation.

    (3)

    The percent of class was calculated based on 118,159,500 shares of Class A Common Stock outstanding as of November 2, 2023, as set forth in the Issuer’s Form 10-Q for the period ended September 30, 2023, and filed with the Securities and Exchange Commission on November 9, 2023.

    (4)

    Pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, the Class B Common Stock beneficially owned by the reporting person is treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person.


    CUSIP No. 26622P107    SCHEDULE 13G    Page 5 of 10 Pages

     

     1.   

     NAMES OF REPORTING PERSONS

     

     Emergence Equity Partners VI, L.P.

     2.  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3.  

     SEC USE ONLY

     

     4.  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.    

     SOLE VOTING POWER

     

     775,000 (1)

       6.   

     SHARED VOTING POWER

     

     -0-

       7.   

     SOLE DISPOSITIVE POWER

     

     775,000 (1)

       8.   

     SHARED DISPOSITIVE POWER

     

     -0-

     9.   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     775,000 (1)

    10.  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11.  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

     0.7% (2)

    12.  

     TYPE OF REPORTING PERSON

     

     PN

     

    (1)

    Represents 775,000 shares of Class A Common Stock held directly by Emergence Capital Opportunity I, L.P. (“ECO I”). Emergence Equity Partners VI, L.P., is the sole general partner of ECO I, and may be deemed to beneficially own the shares of stock held directly by ECO I.

    (2)

    The percent of class was calculated based on 118,159,500 shares of Class A Common Stock outstanding as of November 2, 2023, as set forth in the Issuer’s Form 10-Q for the period ended September 30, 2023, and filed with the Securities and Exchange Commission on November 9, 2023.


    CUSIP No. 26622P107    SCHEDULE 13G    Page 6 of 10 Pages

     

     1.   

     NAMES OF REPORTING PERSONS

     

     Emergence GP Partners, LLC

     2.  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3.  

     SEC USE ONLY

     

     4.  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.    

     SOLE VOTING POWER

     

     15,237,728 (1)(2)

       6.   

     SHARED VOTING POWER

     

     -0-

       7.   

     SOLE DISPOSITIVE POWER

     

     15,237,728 (1)(2)

       8.   

     SHARED DISPOSITIVE POWER

     

     -0-

     9.   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     15,237,728 (1)(2)

    10.  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11.  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

     11.5% (2)(3)(4)

    12.  

     TYPE OF REPORTING PERSON

     

     OO

     

    (1)

    Represents 14,462,728 shares of Class B Common Stock held directly by ECP II and 775,000 shares of Class A Common Stock held directly by ECO I.

    (2)

    Each share of Class A Common Stock is entitled to one vote, and each share of Class B Common Stock is entitled to ten votes. Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon certain events specified in the Issuer’s certificate of incorporation.

    (3)

    The percent of class was calculated based on 118,159,500 shares of Class A Common Stock outstanding as of November 2, 2023, as set forth in the Issuer’s Form 10-Q for the period ended September 30, 2023, and filed with the Securities and Exchange Commission on November 9, 2023.

    (4)

    Pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, the Class B Common Stock beneficially owned by the reporting person is treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person.


    CUSIP No. 26622P107    SCHEDULE 13G    Page 7 of 10 Pages

     

    Item 1.       Issuer
       (a)    Name of Issuer:
          Doximity, Inc. (the “Issuer”)
       (b)    Address of Issuer’s Principal Executive Offices:
         

    500 3rd Street

    Suite 510

    San Francisco, California 94107

    Item 2.       Filing Person
       (a) – (c)    Name of Persons Filing; Address; Citizenship:
            

    (i) Emergence Capital Partners II, L.P., a Delaware limited partnership;

     

    (ii)  Emergence Capital Opportunity I, L.P., a Delaware limited partnership;

     

    (iii)  Emergence Equity Partners II, L.P., a Delaware limited partnership;

     

    (iv) Emergence Equity Partners VI, L.P., a Delaware limited partnership; and

     

    (v)   Emergence GP Partners, LLC, a Delaware limited liability company.

          The address of the principal business office of each of the reporting persons are 5 Pier, Ste. 102, San Francisco, CA 94111.
       (d)    Title of Class of Securities:
          Class A Common Stock, $0.001 par value per share, (the “Common Stock”)
       (e)    CUSIP Number:
          26622P107
    Item 3.    If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
       (a)    ☐    Broker or dealer registered under Section 15 of the Act;
       (b)    ☐    Bank as defined in Section 3(a)(6) of the Act;
       (c)    ☐    Insurance company as defined in Section 3(a)(19) of the Act;
       (d)    ☐    Investment company registered under Section 8 of the Investment Company Act of 1940;
       (e)    ☐    An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
       (f)    ☐    An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
       (g)    ☐    A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
       (h)    ☐    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       (i)    ☐    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
       (j)    ☐    A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
       (k)    ☐    Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
          If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:


    CUSIP No. 26622P107    SCHEDULE 13G    Page 8 of 10 Pages

     

    Item 4.   Ownership.
      (a) and (b)   Amount beneficially owned:
        (i)    Emergence Capital Partners II, L.P. (“ECP II”) directly owns 14,462,728 shares of Class B Common Stock, which, when such shares are treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, represents approximately 10.9% of the outstanding shares of Class A Common Stock.
        (ii)    Emergence Capital Opportunity I, L.P. (“ECO I”) directly owns 775,000 shares of Class A Common Stock, which, represents approximately 0.7% of the outstanding shares of Class A Common Stock.
        (iii)    Emergence Equity Partners II, L.P. (“EEP II”) is the sole general partner of ECP II, and may be deemed to beneficially own 14,462,728 shares of Class B Common Stock, which, when such shares are treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, represents approximately 10.9% of the outstanding shares of Class A Common Stock.
        (iv)    Emergence Equity Partners VI, L.P. (“EEP VI”) is the sole general partner of ECO I, and may be deemed to beneficially own 775,000 shares of Class A Common Stock, which, represents approximately 0.7% of the outstanding shares of Class A Common Stock.
        (v)    Emergence GP Partners, LLC (“EGP”) is the sole general partner of EEP II and the sole general partner of EEP VI, and may be deemed to beneficially own 14,462,728 shares of Class B Common Stock and 775,000 shares of Class A Common Stock held directly by ECP II and ECO I, respectively, which, when such shares of Class B Common Stock are treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, represents approximately 11.5% of the outstanding shares of Class A Common Stock.
           The percent of class was calculated based on 118,159,500 shares of Class A Common Stock outstanding as of November 2, 2023, as set forth in the Issuer’s Form 10-Q for the period ended September 30, 2023, and filed with the Securities and Exchange Commission on November 9, 2023.
      (c)   Number of shares as to which such person has:

     

         Number of Shares of Class A Common Stock  

    Reporting Person

       (i)      (ii)      (II)      (iv)  

    Emergence Capital Partners II, L.P.

         14,462,728        -0-        14,462,728        -0-  

    Emergence Capital Opportunity I, L.P.

         775,000        -0-        775,000        -0-  

    Emergence Equity Partners II, L.P.

         14,462,728        -0-        14,462,728        -0-  

    Emergence Equity Partners VI, L.P.

         775,000        -0-        775,000        -0-  

    Emergence GP Partners, LLC

         15,237,728        -0-        15,237,728        -0-  

     

    (i) Sole power to vote or direct the vote

     

    (ii)  Shared power to vote or to direct the vote

     

    (iii)  Sole power to dispose or to direct the disposition of

     

    (iv) Shared power to dispose or to direct the disposition of

     

      The percent of class was calculated based on 118,159,500 shares of Class A Common Stock outstanding as of November 2, 2023, as set forth in the Issuer’s Form 10-Q for the period ended September 30, 2023, and filed with the Securities and Exchange Commission on November 9, 2023.
    Item 5.  

    Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. ☐

    Item 6.  

    Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.


    CUSIP No. 26622P107    SCHEDULE 13G    Page 9 of 10 Pages

     

    Item 7.   

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

     

    Not applicable.

    Item 8.   

    Identification and Classification of Members of the Group.

     

    Not applicable.

    Item 9.   

    Notice of Dissolution of Group.

     

    Not applicable.

    Item 10.   

    Certification .

     

    Not applicable.


    CUSIP No. 26622P107    SCHEDULE 13G    Page 10 of 10 Pages

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: February 14, 2024

     

    EMERGENCE CAPITAL PARTNERS II, L.P.
    By: Emergence Equity Partners II, L.P., its sole general partner
    By: Emergence GP Partners, LLC, its sole general partner
    By:  

    /s/ David Singer

      Name: David Singer
      Title: Attorney-in-Fact
    EMERGENCE CAPITAL OPPORTUNITY I, L.P.
    By: Emergence Equity Partners VI, L.P., its sole general partner
    By: Emergence GP Partners, LLC, its sole general partner
    By:  

    /s/ David Singer

      Name: David Singer
      Title: Attorney-in-Fact
    EMERGENCE EQUITY PARTNERS II, L.P.
    By: Emergence GP Partners, LLC, its sole general partner
    By:  

    /s/ David Singer

      Name: David Singer
      Title: Attorney-in-Fact
    EMERGENCE EQUITY PARTNERS VI, L.P.
    By: Emergence GP Partners, LLC, its sole general partner
    By:  

    /s/ David Singer

      Name: David Singer
      Title: Attorney-in-Fact
    EMERGENCE GP PARTNERS, LLC
    By:  

    /s/ David Singer

      Name: David Singer
      Title: Attorney-in-Fact
    Get the next $DOCS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DOCS

    DatePrice TargetRatingAnalyst
    7/9/2025$70.00In-line → Outperform
    Evercore ISI
    6/2/2025$80.00Neutral → Buy
    BTIG Research
    2/7/2025$31.00 → $78.00Neutral → Overweight
    Piper Sandler
    2/7/2025$60.00 → $90.00Market Perform → Outperform
    Leerink Partners
    12/20/2024$55.00Equal-Weight
    Stephens
    12/4/2024$55.00Neutral
    Mizuho
    11/15/2024$58.00Neutral
    Goldman
    11/14/2024$33.00 → $53.00Underweight → Equal-Weight
    Morgan Stanley
    More analyst ratings

    $DOCS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Doximity upgraded by Evercore ISI with a new price target

    Evercore ISI upgraded Doximity from In-line to Outperform and set a new price target of $70.00

    7/9/25 8:09:33 AM ET
    $DOCS
    EDP Services
    Technology

    Doximity upgraded by BTIG Research with a new price target

    BTIG Research upgraded Doximity from Neutral to Buy and set a new price target of $80.00

    6/2/25 8:38:31 AM ET
    $DOCS
    EDP Services
    Technology

    Doximity upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Doximity from Neutral to Overweight and set a new price target of $78.00 from $31.00 previously

    2/7/25 9:03:46 AM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    SEC Filings

    View All

    Doximity Inc. filed SEC Form 8-K: Leadership Update

    8-K - Doximity, Inc. (0001516513) (Filer)

    8/15/25 4:01:54 PM ET
    $DOCS
    EDP Services
    Technology

    SEC Form 10-Q filed by Doximity Inc.

    10-Q - Doximity, Inc. (0001516513) (Filer)

    8/7/25 4:11:36 PM ET
    $DOCS
    EDP Services
    Technology

    Doximity Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Doximity, Inc. (0001516513) (Filer)

    8/7/25 4:07:58 PM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Doximity Acquires Pathway, a Leader in AI Clinical Reference

    $63M acquisition brings physician AI team and datasets to Doximity's AI suite Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI and evidence-based clinical reference. Physicians make up half of Pathway's team. Over the past seven years, they've assembled one of the largest structured datasets in medicine—purpose-built for AI—spanning nearly every guideline, drug, and landmark trial across all major specialties. Pathway's model outperforms others in clinical accuracy, recently scoring a record 96% on the U.S. Medical Licensing Examination (

    8/7/25 4:02:00 PM ET
    $DOCS
    EDP Services
    Technology

    Doximity Announces Fiscal 2026 First Quarter Financial Results

    Total revenues of $145.9 million, up 15% year-over-year Operating cash flow of $62.1 million, up 51% year-over-year Free cash flow of $60.1 million, up 52% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 first quarter ended June 30, 2025. "We began our year with strong profit growth and record engagement across our newsfeed, workflow, and AI products," said Jeff Tangney, co-founder and CEO of Doximity. "Our AI suite once again grew the fastest, up 5x year-over-year, while more than 630,000 prescribers used our workflow tools to save time and better serve their patients." Doximity Acquire

    8/7/25 4:01:00 PM ET
    $DOCS
    EDP Services
    Technology

    New Doximity Study Shows Modest Physician Pay Growth Amid Deeper Workforce Strain, Reimbursement Pressures

    Physician pay up 3.7%, but challenges remain: 26% gender wage gap, widespread reimbursement concerns, and deepening financial strain on pediatric care Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today released its 2025 Physician Compensation Report. The findings highlight a healthcare workforce under pressure, with modest compensation growth of 3.7%, a persistent gender pay gap of 26%, and growing concern from pediatric physicians about declining reimbursement. "This year's study reflects a profession that's been under strain for years," said Amit Phull, MD, chief clinical experience officer at Doximity. "Pediatricians and pediatric subspecia

    7/31/25 5:00:00 AM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Bryson Anna covered exercise/tax liability with 5,120 shares, decreasing direct ownership by 1% to 346,925 units (SEC Form 4)

    4 - Doximity, Inc. (0001516513) (Issuer)

    8/15/25 8:24:18 PM ET
    $DOCS
    EDP Services
    Technology

    Chief Executive Officer Tangney Jeffrey covered exercise/tax liability with 7,990 shares, decreasing direct ownership by 0.35% to 2,249,058 units (SEC Form 4)

    4 - Doximity, Inc. (0001516513) (Issuer)

    8/15/25 8:21:54 PM ET
    $DOCS
    EDP Services
    Technology

    Director Benjamin Regina M. converted options into 5,000 shares and sold $315,000 worth of shares (5,000 units at $63.00) (SEC Form 4)

    4 - Doximity, Inc. (0001516513) (Issuer)

    8/11/25 4:02:32 PM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    Leadership Updates

    Live Leadership Updates

    View All

    Parspec Raises $20 Million Series A to Modernize the Construction Supply Chain with AI

    SAN MATEO, Calif., July 8, 2025 /PRNewswire/ -- Parspec, an AI-native software platform that enables wholesale distributors and sales agents to efficiently bid and supply construction products, today announced it has raised $20 million in Series A funding. The round was led by Threshold Ventures (formerly DFJ), with participation from existing venture investors including Innovation Endeavors, Building Ventures, Heartland Ventures, and Hometeam Ventures. Parspec Raises $20 Million Series A to Modernize the Construction Supply Chain with AIThe global construction industry repres

    7/8/25 9:30:00 AM ET
    $BOX
    $DOCS
    $RELY
    Computer Software: Prepackaged Software
    Technology
    EDP Services
    Business Services

    Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

    With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera's efforts to scale robotics and AI across mainstream medical procedures. The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver high-quality care to pati

    9/26/24 6:05:00 AM ET
    $DOCS
    $RELY
    $LVGO
    EDP Services
    Technology
    Business Services
    Consumer Discretionary

    Doximity Appoints Phoebe Yang to Its Board of Directors

    Experienced director and executive brings health system and cloud expertise SAN FRANCISCO, Aug. 4, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced the appointment of Phoebe L. Yang to its Board of Directors. Ms. Yang has been General Manager at Amazon Web Services, Healthcare, and a member of the board of directors for CommonSpirit Health, one of the largest U.S. health systems. Ms. Yang is a long-time member of the Council on Foreign Relations, and has served as an appointee in two Presidential Administrations. In 2021, she was named one of Modern Healthcare's Top 100 Most Influential People in Healthcare and one

    8/4/22 4:02:00 PM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    Financials

    Live finance-specific insights

    View All

    Doximity Acquires Pathway, a Leader in AI Clinical Reference

    $63M acquisition brings physician AI team and datasets to Doximity's AI suite Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI and evidence-based clinical reference. Physicians make up half of Pathway's team. Over the past seven years, they've assembled one of the largest structured datasets in medicine—purpose-built for AI—spanning nearly every guideline, drug, and landmark trial across all major specialties. Pathway's model outperforms others in clinical accuracy, recently scoring a record 96% on the U.S. Medical Licensing Examination (

    8/7/25 4:02:00 PM ET
    $DOCS
    EDP Services
    Technology

    Doximity Announces Fiscal 2026 First Quarter Financial Results

    Total revenues of $145.9 million, up 15% year-over-year Operating cash flow of $62.1 million, up 51% year-over-year Free cash flow of $60.1 million, up 52% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 first quarter ended June 30, 2025. "We began our year with strong profit growth and record engagement across our newsfeed, workflow, and AI products," said Jeff Tangney, co-founder and CEO of Doximity. "Our AI suite once again grew the fastest, up 5x year-over-year, while more than 630,000 prescribers used our workflow tools to save time and better serve their patients." Doximity Acquire

    8/7/25 4:01:00 PM ET
    $DOCS
    EDP Services
    Technology

    Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025

    Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2025 after market close on August 7, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include mor

    7/17/25 4:01:00 PM ET
    $DOCS
    EDP Services
    Technology

    $DOCS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Doximity Inc.

    SC 13G/A - Doximity, Inc. (0001516513) (Subject)

    11/14/24 5:22:01 PM ET
    $DOCS
    EDP Services
    Technology

    SEC Form SC 13G filed by Doximity Inc.

    SC 13G - Doximity, Inc. (0001516513) (Subject)

    11/14/24 11:42:53 AM ET
    $DOCS
    EDP Services
    Technology

    SEC Form SC 13G filed by Doximity Inc.

    SC 13G - Doximity, Inc. (0001516513) (Subject)

    11/12/24 9:55:17 AM ET
    $DOCS
    EDP Services
    Technology